Compare
NAVs as of 20 Aug 2026
Add a second fund to compare. Until then every figure below is shown against the Other ETFs median (248 funds), which is the only comparison one fund can support.
Growth of ₹100 (rebased over the selected window)
Common period 13 Jan 2022 – 20 Aug 2026, limited by ICICI Prudential Nifty Auto ETF. Every series is rebased to ₹100 at the start of this window. Benchmark lines are the category index WealthTicker measures against, which is not always the benchmark the scheme itself declares — the fund page’s Scheme Info names that one.
View as table
| Date | ICICI Prudential Nifty Auto ETF | Nifty 500 |
|---|---|---|
| 13 Jan 2022 | ₹100.00 | ₹100.00 |
| 02 Jun 2022 | ₹98.56 | ₹90.12 |
| 20 Oct 2022 | ₹110.00 | ₹96.13 |
| 09 Mar 2023 | ₹110.45 | ₹94.17 |
| 27 Jul 2023 | ₹134.95 | ₹107.62 |
| 14 Dec 2023 | ₹156.75 | ₹120.69 |
| 02 May 2024 | ₹197.40 | ₹134.11 |
| 19 Sep 2024 | ₹226.44 | ₹151.73 |
| 06 Feb 2025 | ₹203.54 | ₹137.86 |
| 26 Jun 2025 | ₹209.62 | ₹149.59 |
| 13 Nov 2025 | ₹240.94 | ₹151.49 |
| 02 Apr 2026 | ₹212.16 | ₹133.19 |
| 20 Aug 2026 | ₹260.03 | ₹149.56 |
| Metric | ICICI Prudential NAV ₹30.38 Very High risk ★★★★★ | Category median Other ETFs · 248 funds |
|---|---|---|
| +16.08% | +3.65% | |
| +24.73% | +10.51% | |
| — | +9.28% | |
| — | +11.93% | |
| +23.09% | +10.38% | |
| +23.40% | — | |
| +26.99% | +14.30% | |
| — | +13.74% | |
| — | +12.83% | |
| Risk | ||
| 19.30% | 15.45% | |
| 0.94 | 0.28 | |
| 1.37 | 0.41 | |
| -28.25% | -20.59% | |
| Nifty 500 | — | |
| +11.09% | +0.80% | |
| 1.08 | 1.00 | |
| 142.1% | 102.1% | |
| 99.2% | 96.4% | |
| 0.20% | 0.32% | |
| ₹195.99Cr | ₹137.31Cr | |
| — | — | |
| — | — | |
| — | — | |
| — | — | |
| — | — | |
| Ashwini Bharucha | — | |
| 13 Jan 2022 | — | |
| 15 | — | |
| 88.6% | — | |
| — | — | |
Best marks the strongest value in a row, and only where the gap is bigger than noise — a near-tie is left unmarked rather than dressed up as a result. SIP XIRR is a ₹10,000/month instalment over 5 years of real NAV history. Nothing here is supplied by a fund house. For research only — not investment advice.